50 results
DEFM14A
ISEE
IVERIC bio Inc
5 Jun 23
Proxy related to merger
8:54am
.
Wall Street Analysts Price Targets. BofA Securities reviewed certain publicly available equity research analyst price targets for our common stock … price targets for the shares of our common stock in publicly available Wall Street research analyst reports as of April 27, 2023, which indicated low
PREM14A
ISEE
IVERIC bio Inc
23 May 23
Preliminary proxy related to merger
6:49am
Street Analysts Price Targets. BofA Securities reviewed certain publicly available equity research analyst price targets for our common stock available … targets for the shares of our common stock in publicly available Wall Street research analyst reports as of April 27, 2023, which indicated low and high
DEFA14A
EX-99.1
ISEE
IVERIC bio Inc
1 May 23
Additional proxy soliciting materials
7:05am
that the acquisition of Iveric Bio will not only contribute to Astellas' FY2025 revenue targets set in its Corporate Strategic Plan 2021, but also, that ACP
8-K
EX-99.1
ISEE
IVERIC bio Inc
1 May 23
Astellas Enters into Definitive Agreement
7:02am
that the acquisition of Iveric Bio will not only contribute to Astellas' FY2025 revenue targets set in its Corporate Strategic Plan 2021, but also, that ACP
424B5
suboth
22 Oct 21
Prospectus supplement for primary offering
4:02pm
424B5
kxk2me7
21 Oct 21
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
wbry7merogq0x qqo
21 Oct 21
Other Events
4:04pm